Body mass index, fasting plasma glucose levels, and C-peptide levels as predictors of the future insulin use in Japanese type 2 diabetic patients.
about
Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes.Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function.Postprandial C-peptide to glucose ratio as a predictor of β-cell function and its usefulness for staged management of type 2 diabetesSecretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients.New indices for predicting glycaemic variabilityFactors associated with long-term oral hypoglycemic agent responsiveness in korean patients with type 2 diabetes mellitus.C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus.The clinical utility of C-peptide measurement in the care of patients with diabetesEfficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin.Plasma soluble leptin receptor levels are associated with pancreatic β-cell dysfunction in patients with type 2 diabetes.The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis.Screening of diabetes of youth for hepatocyte nuclear factor 1 mutations: clinical phenotype of HNF1β-related maturity-onset diabetes of the young and HNF1α-related maturity-onset diabetes of the young in Japanese.
P2860
Q33607736-25EACF4A-F69C-4CF2-AA3E-3FF4EE6A86B1Q33607749-C9186588-AD7A-4A17-8051-90AC7FFD5C8FQ34299622-3C349757-E5C2-4280-935F-5C898928DB84Q34299664-27B4F331-9F4B-4447-AF83-43C73E2766F6Q34431371-D14F7094-69FF-4630-8F79-39B075928A5FQ35110336-165AED3F-BABE-41F0-8534-430AE59398FBQ35916079-C46FD85B-1668-41DB-A2C2-CF5D26B81C1CQ37108880-7F1DF6F0-C9CB-4673-8A04-10087F3C770EQ37621228-BA97C1CC-BBA4-41AE-9712-A7DEEF6A2B59Q48127031-875CD88F-6F8E-43C0-8F9D-9F8758D4B82AQ51244688-67B26614-16B8-4A31-838B-7A5E1A1770ADQ51321285-D25C5BAF-09DA-4511-9402-0868CF2B6E05
P2860
Body mass index, fasting plasma glucose levels, and C-peptide levels as predictors of the future insulin use in Japanese type 2 diabetic patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Body mass index, fasting plasm ...... nese type 2 diabetic patients.
@en
Body mass index, fasting plasm ...... nese type 2 diabetic patients.
@nl
type
label
Body mass index, fasting plasm ...... nese type 2 diabetic patients.
@en
Body mass index, fasting plasm ...... nese type 2 diabetic patients.
@nl
prefLabel
Body mass index, fasting plasm ...... nese type 2 diabetic patients.
@en
Body mass index, fasting plasm ...... nese type 2 diabetic patients.
@nl
P2093
P356
P1433
P1476
Body mass index, fasting plasm ...... anese type 2 diabetic patients
@en
P2093
Atsushi Goto
Hiroshi Kajio
Maki Takaichi
Miyako Kishimoto
Takuro Shimbo
Yoshihiko Takahashi
P304
P356
10.1507/ENDOCRJ.K09E-279
P577
2009-12-23T00:00:00Z